GALA MEDICINES LTD

Company Registration Number:
SC537272 (Scotland)

Unaudited abridged accounts for the year ended 30 June 2023

Period of accounts

Start date: 01 July 2022

End date: 30 June 2023

GALA MEDICINES LTD

Contents of the Financial Statements

for the Period Ended 30 June 2023

Balance sheet
Notes

GALA MEDICINES LTD

Balance sheet

As at 30 June 2023


Notes

2023

2022


£

£
Fixed assets
Tangible assets: 3 327,742 335,269
Total fixed assets: 327,742 335,269
Current assets
Stocks: 65,980 68,450
Debtors:   524,550 453,221
Cash at bank and in hand: 117,736 116,139
Total current assets: 708,266 637,810
Creditors: amounts falling due within one year:   (129,420) (115,458)
Net current assets (liabilities): 578,846 522,352
Total assets less current liabilities: 906,588 857,621
Creditors: amounts falling due after more than one year:   (247,498) (292,841)
Total net assets (liabilities): 659,090 564,780
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 658,990 564,680
Shareholders funds: 659,090 564,780

The notes form part of these financial statements

GALA MEDICINES LTD

Balance sheet statements

For the year ending 30 June 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 29 March 2024
and signed on behalf of the board by:

Name: UMAR RAZZAQ
Status: Director

The notes form part of these financial statements

GALA MEDICINES LTD

Notes to the Financial Statements

for the Period Ended 30 June 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

GALA MEDICINES LTD

Notes to the Financial Statements

for the Period Ended 30 June 2023

2. Employees

2023 2022
Average number of employees during the period 5 5

GALA MEDICINES LTD

Notes to the Financial Statements

for the Period Ended 30 June 2023

3. Tangible Assets

Total
Cost £
At 01 July 2022 370,545
At 30 June 2023 370,545
Depreciation
At 01 July 2022 35,276
Charge for year 7,527
At 30 June 2023 42,803
Net book value
At 30 June 2023 327,742
At 30 June 2022 335,269